Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-035493

Director acquired 4,491,310 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FOLLMAN ROBERT J Director 2013-06-14 Conversion +4,491,310 $0.05 $211,990 4,491,310 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
FOLLMAN ROBERT J Director 2013-01-25 Conversion · Convertible Note −0 0 I: show line 2 in the form
Loading xslF345X03/v348019_4.xml…